CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
by whole-body PET-CT imaging in participants with convalescent COVID-19. Up to 80 participants will be enrolled over an accrual per...
Phase 2
San Francisco, California, United States
The purpose of this study is to learn about the safety, tolerability, and immunogenicity of an updated vaccine against COVID-19.Thi-...
Phase 3
Walnut Creek, Colorado, United States of America and 5 other locations
The purpose of this study is to learn about how the flu and COVID vaccines act when given alone or when mixed together.This study is seeking healthy...
Phase 1, Phase 2
Walnut Creek, Colorado, United States of America and 30 other locations
The purpose of the study is to evaluate whether ibuzatrelvir is effective and safe in adults and adolescents with COVID-19 who do n...
Phase 3
Walnut Creek, California, United States and 143 other locations
Researchers are looking for other ways to prevent severe illness from COVID-19. COVID-19 is a virus that most oft-...
Phase 3
San Francisco, California, United States and 195 other locations
studies or substudies based on age group and prior history of COVID-19 vaccinations. All participants in each of the 5 sub-studies ...
Phase 2, Phase 3
Oakland, California, United States and 114 other locations
the study vaccine (called COMIRNATY) for the potential prevention of COVID-19. This study is seeking participants who:1. Are age \<...
Phase 4
Palo Alto, California, United States and 31 other locations
This is a Phase 2/3 randomized, observer-blinded, placebo-controlled, age de-escalation trial to evaluate the safety and immunogenicity of 2 primary...
Phase 2, Phase 3
Walnut Creek, California, United States and 94 other locations
There is a pressing need to increase capacity to treat PTSD related to or exacerbated by the COVID-19 pandemic. Texting-based thera...
Palo Alto, California, United States and 2 other locations
This study will test the safety and tolerability of Anktiva in patients with Long Covid. Eligible patients will receive up to 2 doses of Anktiva and...
Phase 2
San Francisco, California, United States
Clinical trials
Research sites
Resources
Legal